Clint Eastwood, The 'Man With No Name' Collects $2M From CBD Company For Using His Name

Zinger Key Points
  • Eastwood wants the world to know he doesn't like cannabis or CBD any more than he does fake endorsements.
  • The 'Man with No Name' is protective of his name as he collects on a second lawsuit against a CBD company.

Clint Eastwood, who took Hollywood by storm in the 1960s as the “Man with No Name" in Sergio Leone's “Dollars Trilogy” is actually quite protective of his name. He is collecting another fistful of dollars in a second successful lawsuit - this time against Norok Innovations, a California-based Internet marketing company.

What Happened: The verdict awarded Eastwood and Garrapata, the company that owns the rights to the actor's likeness, a cool $2 million for using Eastwood’s fame to drive online traffic via a “hidden metatag game” to a website selling CBD products, per The Hollywood Reporter. Fake news articles and manipulated search results made it appear as if Eastwood was endorsing CBD products. 

Apparently, Eastwood took issue with the way Norok lured online shoppers to its website. 

“We are pleased with the Court’s decision as it recognizes the substantial harm that false endorsements cause,” said Eastwood’s attorney Jordan Susman. “It further sends a message to such offenders that they cannot evade liability by ignoring the legal system. This is a judgment we look forward to collecting.”

Eastwood also wants the world to know he does not care for cannabis or CBD any more than he does fake endorsements and online scams.

At 92, the actor, director and producer has been in numerous legal battles over the years to protect his name, image and reputation. Of late, many have been against CBD manufacturers and marketers in an effort to clarify that he's not now and has never been involved in the cannabis industry.

In October 2021 Eastwood was awarded $6.1 million in damages and legal fees against Mediatonas UAB in a similar lawsuit against the Lithuanian company, which also published fake interviews giving the impression that the movie star endorsed its CBD. 

“In truth, Mr. Eastwood has no connection of any kind whatsoever to any CBD products and never gave such an interview,” said the lawsuit against Mediatonas, which was filed in Los Angeles federal court in July 2020.

Photo: Courtesy of Siebbi on Flickr

Posted In: CBDGarrapataJordan SusmanMan with No NameMediatonas UABNorok Innovationsonline scamsSergio LeoneCannabisEntertainmentNewsLegalMarketsMediaGeneral

Ad Disclosure: The rate information is obtained by Bankrate from the listed institutions. Bankrate cannot guaranty the accuracy or availability of any rates shown above. Institutions may have different rates on their own websites than those posted on The listings that appear on this page are from companies from which this website receives compensation, which may impact how, where, and in what order products appear. This table does not include all companies or all available products.

All rates are subject to change without notice and may vary depending on location. These quotes are from banks, thrifts, and credit unions, some of whom have paid for a link to their own Web site where you can find additional information. Those with a paid link are our Advertisers. Those without a paid link are listings we obtain to improve the consumer shopping experience and are not Advertisers. To receive the rate from an Advertiser, please identify yourself as a Bankrate customer. Bank and thrift deposits are insured by the Federal Deposit Insurance Corp. Credit union deposits are insured by the National Credit Union Administration.

Consumer Satisfaction: Bankrate attempts to verify the accuracy and availability of its Advertisers' terms through its quality assurance process and requires Advertisers to agree to our Terms and Conditions and to adhere to our Quality Control Program. If you believe that you have received an inaccurate quote or are otherwise not satisfied with the services provided to you by the institution you choose, please click here.

Rate collection and criteria: Click here for more information on rate collection and criteria.